Brand Name:

Flubiovir^®

Dosage:

75 mg

Generic Name:

Oseltamivir

Pharmacotherapeutic Group:

Antiviral (systemic)

Therapeutic Indication:

Oseltamivir:

Influenza infection:

Treatment - Treatment of uncomplicated acute illness caused by influenza infection in patients >1 year of age who have been symptomatic for ≤2 days.
Prophylaxis - For prophylaxis of influenza in adults and adolescents ≥13 years of age. Oseltamivir is not substitute for early vaccination on an annual basis.

Dosage and Administration:

• Treatment of influenza: Adults and Adolescents (≥13 years): the recommended oral dose of oseltamivir is 75mg twice daily for 5 days. Begin treatment within 2days of onset of influenza symptoms.
• Influenza prophylaxis: The recommended oral dose of oseltamivir for influenza prophylaxis in adults and adolescents ≥13 years of age following close contact with an infected individual is 75mg once daily for ≥7 days. Therapy should begin within 2 days of exposure. The recommended dose for prophylaxis during a community outbreak of influenza is 75mg once daily.

Side Effects:

• CNS: Vertigo, Headache, Insomnia, Dizziness.
• GI: Vomiting, Nausea (without vomiting), Abdominal pain, Diarrhea.
• Resp: Bronchitis, Cough, (in pediatric patients): Asthma
• Otic (in pediatric patients): Ear disorder, Otitis media, Tympanic membrane disorder.
• Other: Fatigue, Epistaxis, Conjunctivitis, Sinusitis, dermatitis, lymphadenopathy, Skin and subcutaneous tissue disorder, rush (very rare)